Enveric Biosciences Inc Financial Flexibility Index
Enveric Biosciences Inc financial flexibility index. Enveric Biosciences Inc (ENVB) has a Financial Flexibility Index of -2.29x as of September 2025. Free cash flow of $-2.07 Million (operating CF $-2.07 Million minus capex $4.00) represents -2% of total liabilities ($905.88K). See Enveric Biosciences Inc (ENVB) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Enveric Biosciences Inc (1994–2024)
Financial flexibility index of Enveric Biosciences Inc from 1994 to 2024. Historical Financial Flexibility Index trend for Enveric Biosciences Inc across 31 annual periods. Check cash flow quality index of Enveric Biosciences Inc to evaluate the quality of earnings relative to operating cash generation.
Enveric Biosciences Inc Financial Flexibility Index by Year (1994–2024)
Enveric Biosciences Inc financial flexibility index by year from 1994 to 2024. Year-by-year free cash flow to debt coverage for Enveric Biosciences Inc. For the full cash flow conversion analysis, see Enveric Biosciences Inc (ENVB) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -5.19x | $-7.73 Million | $-7.73 Million | $1.49 Million | ▲ +13.7% |
| 2023 | -6.01x | $-14.09 Million | $-14.09 Million | $2.34 Million | ▼ -45.0% |
| 2022 | -4.14x | $-16.56 Million | $-17.15 Million | $4.00 Million | ▼ -72.7% |
| 2021 | -2.40x | $-10.59 Million | $-11.46 Million | $4.41 Million | ▲ +57.5% |
| 2020 | -5.64x | $-3.84 Million | $-3.89 Million | $681.25K | ▼ -14304.6% |
| 2019 | -0.04x | $-563.53K | $-647.86K | $14.38 Million | ▲ +68.9% |
| 2018 | -0.13x | $-2.38 Million | $-2.57 Million | $18.88 Million | ▼ -50.6% |
| 2017 | -0.08x | $-2.74 Million | $-2.74 Million | $32.75 Million | ▼ -336.2% |
| 2016 | 0.04x | $985.01K | $-2.70 Million | $27.84 Million | ▲ +124.2% |
| 2015 | -0.15x | $-1.99 Million | $-3.67 Million | $13.58 Million | ▲ +97.0% |
| 2014 | -4.82x | $-43.16K | $-43.16K | $8.96K | ▼ -450.2% |
| 2013 | -0.88x | $-21.63K | $-21.63K | $24.70K | ▲ +9.5% |
| 2012 | -0.97x | $-24.85K | $-24.85K | $25.67K | ▲ +42.9% |
| 2011 | -1.70x | $-30.35K | $-30.35K | $17.89K | ▼ -111.2% |
| 2010 | -0.80x | $-40.67K | $-40.67K | $50.64K | ▲ +85.3% |
| 2009 | -5.48x | $-65.04K | $-65.04K | $11.87K | ▲ +22.6% |
| 2008 | -7.08x | $-150.19K | $-150.19K | $21.21K | ▼ -202.8% |
| 2007 | 6.89x | $329.93K | $329.93K | $47.90K | ▲ +306.2% |
| 2006 | -3.34x | $-290.89K | $-305.91K | $87.08K | ▼ -138.7% |
| 2005 | -1.40x | $-251.29K | $-256.57K | $179.52K | ▼ -368.1% |
| 2004 | 0.52x | $347.95K | $343.94K | $666.31K | ▲ +151.7% |
| 2003 | -1.01x | $-252.19K | $-253.97K | $249.77K | ▼ -299.9% |
| 2002 | 0.51x | $160.13K | $85.14K | $317.01K | ▲ +154.0% |
| 2001 | -0.94x | $-319.36K | $-339.68K | $341.54K | ▼ -504.7% |
| 2000 | 0.23x | $186.33K | $145.84K | $806.35K | ▲ +148.6% |
| 1999 | -0.48x | $-642.28K | $-665.38K | $1.35 Million | ▲ +60.1% |
| 1998 | -1.19x | $-2.92 Million | $-3.00 Million | $2.45 Million | ▲ +40.2% |
| 1997 | -2.00x | $-3.27 Million | $-3.70 Million | $1.64 Million | ▲ +60.8% |
| 1996 | -5.08x | $-4.44 Million | $-4.72 Million | $873.32K | ▼ -4.7% |
| 1995 | -4.86x | $-3.40 Million | $-3.60 Million | $700.00K | ▼ -524.5% |
| 1994 | -0.78x | $-700.00K | $-800.00K | $900.00K | — |